Literature DB >> 8592526

Autoantibodies against erythropoietin in a patient with pure red-cell aplasia.

N Casadevall1, E Dupuy, P Molho-Sabatier, G Tobelem, B Varet, P Mayeux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8592526     DOI： 10.1056/NEJM199603073341004

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  31 in total

Review 1.  Anemia of Central Origin.

Authors:  Kazusa Ishii; Neal S Young
Journal:  Semin Hematol       Date:  2015-07-09       Impact factor: 3.851

2.  Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin.

Authors:  M Voulgarelis; S I Kokori; J P Ioannidis; A G Tzioufas; D Kyriaki; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

Review 3.  Current methods for detecting antibodies against erythropoietin and other recombinant proteins.

Authors:  Robin Thorpe; Steven J Swanson
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

Review 4.  Pure red cell aplasia associated with type I autoimmune polyglandular syndrome-successful response to treatment with mycophenolate mofetil: case report and review of literature.

Authors:  Milena Bakrac; Vladimir Jurisic; Tanja Kostic; Vera Popovic; Sandra Pekic; Nada Kraguljac; Milica Colovic
Journal:  J Clin Pathol       Date:  2007-01-12       Impact factor: 3.411

Review 5.  Today's challenges in pharmacovigilance: what can we learn from epoetins?

Authors:  Hans C Ebbers; Aukje K Mantel-Teeuwisse; Ellen H M Moors; Huub Schellekens; Hubert G Leufkens
Journal:  Drug Saf       Date:  2011-04-01       Impact factor: 5.606

Review 6.  Lessons learned from bone marrow failure in systemic lupus erythematosus: Case reports and review of the literature.

Authors:  Erik Anderson; Bhakti Shah; Anne Davidson; Richard Furie
Journal:  Semin Arthritis Rheum       Date:  2017-12-08       Impact factor: 5.532

Review 7.  Immunogenicity Risk Assessment for an Engineered Human Cytokine Analogue Expressed in Different Cell Substrates.

Authors:  Paul Chamberlain; Bonita Rup
Journal:  AAPS J       Date:  2020-04-14       Impact factor: 4.009

Review 8.  Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.

Authors:  S Giannouli; M Voulgarelis; P D Ziakas; A G Tzioufas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

9.  Improvement in erythropoieis-stimulating agent-induced pure red-cell aplasia by introduction of darbepoetin-α when the anti-erythropoietin antibody titer declines spontaneously.

Authors:  Hajeong Lee; Jaeseok Yang; Hyosang Kim; Ju Won Kwon; Kook-Hwan Oh; Kwon Wook Joo; Yon Su Kim; Curie Ahn; Jin Suk Han; Suhnggwon Kim
Journal:  J Korean Med Sci       Date:  2010-10-26       Impact factor: 2.153

Review 10.  Biosimilar erythropoiesis-stimulating agents and the risk of developing anti-drug antibodies-a systematic review.

Authors:  Marianne Heibert Arnlind; Linda Fryklund; Sigurd Vitols; Göran Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2016-07-21       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.